Bupivacaine versus lignocaine as the choice of locall anesthetic agent for impacted third molar surgery a review

K Balakrishnan, Vijay Ebenezer, Abu Dakir, Saravana Kumar, D Prakash, K Balakrishnan, Vijay Ebenezer, Abu Dakir, Saravana Kumar, D Prakash

Abstract

One of the most important goal in minor surgical procedures is to achieve proper and sufficient anesthesia and analgesia preoperatively, intraoperatively and in the immediate postoperative period. Several local anesthetic agents have been cited in the literature and studied. Bupivacaine is one of the most common long-acting anesthetic agents being used for surgical removal of impacted third molars. Lignocaine is one of the commonest short-acting anesthetic agents being used for the same procedure. In this review article, the analgesic and anesthetic abilities of the bupivacaine versus lignocaine have been reviewed while surgical removal of impacted third molars.

Keywords: Analgesia; anesthesia; bupivacaine; lignocaine; postoperative period.

Conflict of interest statement

Conflict of Interest: None declared.

References

    1. Cepeda MS, Tzortzopoulou A, Thackrey M, Hudcova J, Arora Gandhi P, Schumann R. Adjusting the pH of lidocaine for reducing pain on injection. Cochrane Database Syst Rev. 2010 CD006581. doi: 10.1002/14651858.CD006581.pub2.
    1. Khaliq W, Alam S, Puri N. Topical lidocaine for the treatment of postherpetic neuralgia. Cochrane Database Syst Rev. 2013;10:CD004846.
    1. “New Hope for Tinnitus Sufferers”. BBC News; 9 January. 2008
    1. Kalcioglu MT, Bayindir T, Erdem T, Ozturan O. Objective evaluation of the effects of intravenous lidocaine on tinnitus. Hear Res. 2005;199:81–8.
    1. Lewin NA, Nelson LH. Antidysrhythmics”. In: Flomenbaum N, Goldfrank LR, Hoffman RL, Howland MD, Lewin NA, Nelson LH, editors. Goldfrank's Toxicologic Emergencies. 8th ed. Ch. 61. New York: McGraw-Hill; 2006. pp. 963–4.
    1. Thomson PD, Melmon KL, Richardson JA, Cohn K, Steinbrunn W, Cudihee R, et al. Lidocaine pharmacokinetics in advanced heart failure, liver disease, and renal failure in humans. Ann Intern Med. 1973;78:499–508.
    1. Collinsworth KA, Kalman SM, Harrison DC. The clinical pharmacology of lidocaine as an antiarrhythymic drug. Circulation. 1974;50:1217–30.
    1. “Bupivacaine Hydrochloride (Bupivacaine Hydrochloride) Injection, Solution”. FDA. [Last retrieved on 2014 Apr 20].
    1. Rosenquist JB, Rosenquist KI, Lee PK. Comparison between lidocaine and bupivacaine as local anesthetics with diflunisal for postoperative pain control after lower third molar surgery. Anesth Prog. 1988;35:1–4.
    1. Chapman PJ, Macleod AW. A clinical study of bupivacaine for mandibular anesthesia in oral surgery. Anesth Prog. 1985;32:69–72.
    1. de Jong RH, Bonin JD. Local anesthetics: Injection route alters relative toxicity of bupivacaine. Anesth Analg. 1980;59:925–8.
    1. Boulox GF. Bupivacaine versus lignocaine for third molar surgery; a double blind randomized crossover study. J Oral Maxillofac Surg. 1999;57:10–514.
    1. Christensen J, Matzen LH, Vaeth M, Wenzel A, Schou S. Efficiency of bupivacaine versus lidocaine and methylprednisolone versus placebo to reduce postoperative pain and swelling after surgical removal of mandibular third molars: A randomized, double-blinded, crossover clinical trial. J Oral Maxillofac Surg. 2013;71:1490–9.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner